As analysts anticipate the July 15 earnings report, they expect a year-over-year decline of 38.2 percent with $4.40 per share earnings. Despite this, revenue is expected to increase 11.9 percent over last July’s report, bringing it to $69.55 billion.
However, last quarter’s report surprised analysts with 20.14 percent revenue growth, beating estimates for the fourth time in a row.
Despite previous surprises, analysts still anticipate the dip in revenue come July’s report.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
